We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHT
576
Universal Health Realty Income Trust
UHT
$627M
$9.47K ﹤0.01%
237
-10
-4% -$393
ITOS
577
DELISTED
iTeos Therapeutics
ITOS
$9.32K ﹤0.01%
935
– –
ALX
578
Alexander's
ALX
$1.36B
$9.24K ﹤0.01%
41
-3
-7% -$646
ERAS icon
579
Erasca
ERAS
$6.3B
$9.2K ﹤0.01%
7,240
– –
ARCT icon
580
Arcturus Therapeutics
ARCT
$163M
$9.02K ﹤0.01%
693
– –
MESO
581
Mesoblast
MESO
$1.87B
$8.9K ﹤0.01%
817
– –
FPI
582
Farmland Partners
FPI
$417M
$8.87K ﹤0.01%
771
-87
-10% -$932
MRVI icon
583
Maravai LifeSciences
MRVI
$1.01B
$8.75K ﹤0.01%
3,631
– –
RIGL icon
584
Rigel Pharmaceuticals
RIGL
$712M
$8.45K ﹤0.01%
451
– –
PACB icon
585
Pacific Biosciences
PACB
$432M
$8.42K ﹤0.01%
6,791
– –
CHCT
586
Community Healthcare Trust
CHCT
$543M
$8.37K ﹤0.01%
503
-24
-5% -$396
PRTA icon
587
Prothena Corp
PRTA
$448M
$8.36K ﹤0.01%
1,377
– –
PRME icon
588
Prime Medicine
PRME
$558M
$8.29K ﹤0.01%
3,358
– –
BFS
589
Saul Centers
BFS
$870M
$8.19K ﹤0.01%
240
-10
-4% -$337
TERN
590
DELISTED
Terns Pharmaceuticals
TERN
$8.11K ﹤0.01%
2,174
– –
AURA icon
591
Aura Biosciences
AURA
$729M
$8.01K ﹤0.01%
1,279
– –
XRN
592
Chiron Real Estate Inc
XRN
$541M
$7.95K ﹤0.01%
229
-11
-5% -$383
BCYC
593
Bicycle Therapeutics
BCYC
$275M
$7.83K ﹤0.01%
1,126
– –
ATXS
594
DELISTED
Astria Therapeutics
ATXS
$7.74K ﹤0.01%
1,444
– –
ABSI icon
595
Absci
ABSI
$1.21B
$7.56K ﹤0.01%
2,941
– –
AVIR icon
596
Atea Pharmaceuticals
AVIR
$361M
$7.55K ﹤0.01%
2,096
– –
TECX
597
Tectonic Therapeutic
TECX
$562M
$7.49K ﹤0.01%
377
– –
AQST icon
598
Aquestive Therapeutics
AQST
$472M
$7.49K ﹤0.01%
2,262
– –
OLP
599
One Liberty Properties
OLP
$547M
$7.35K ﹤0.01%
308
-13
-4% -$317
ALMS
600
Alumis Inc
ALMS
$3.45B
$7.22K ﹤0.01%
2,408
+1,236
+105% +$5.84K
22 23
24
25 26

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.